beta 1 Selectivity of drugs: quality of the drug or quality of the patient?

Respiration; International Review of Thoracic Diseases
P von WichertW Teufel

Abstract

In two groups of patients with well-defined obstructive lung disease - a group of bronchitics according to WHO criteria and a group of patients with extrinsic allergic asthma - the effect of carazolol, a so-called non-cardioselective beta-blocking drug, was investigated. Pindolol was used to compare the results with a second blocking drug. Carazolol increased bronchial resistance in the bronchitic group but not in the asthmatic group; with the exception of 1 patient in whom carazolol induced a status asthmaticus. The effect of the drug on bronchial resistance depends only in part upon the drug itself, but was influenced much more by the characteristics of the patients. We therefore conclude that the quality of beta 1-receptorspecificity was, at least in part, a result of the qualities of the patients. The designation of a drug as beta 1-specific should therefore be used very cautiously. Serious side-effects on the bronchial system in particular persons are also possible from drugs shown to be safe in some groups of patients.

Citations

May 1, 1982·Veterinary Research Communications·N G Gregory, L J Wilkins
Jul 1, 1984·Drug Intelligence & Clinical Pharmacy·C D Black, H J Mann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.